can glp 1 prevent cancer GLP-1s may reduce risk for adults with obesity Research Reveals Potential Risks of

Mounjaro doesnt yet carry those specific approvals, though trials are ongoing

Ring et al., 2010

The Sanctuary Wellness Institute works with licensed prescription weight loss doctors who serve patients through physician-supervised telehealth care

Effects on weight reduction and safety of short-term phentermine administration in Korean obese people, Yosei Medical Journal (2006) Once-weekly semaglutide in adults with overweight or obesity, The New England Journal of Medicine (2021) Ozempic (semaglutide) injection prescribing information, Food and Drug Administration (2023) Phentermine hydrochloride tablets prescribing information, Food and Drug Administration (2017) Semaglutide, StatPearls (2024) Three- and six-month efficacy and safety of phentermine in a Mexican obese population, International Journal of Clinical Pharmacology and Therapeutics (2021) Topiramate and phentermine, StatPearls (2023) Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity, JAMA Network Open (2022) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice

North Coast Medical, CA)

However, Ozempic is represented to be one of the GLP-1 receptor agonist medicines that was primarily developed to treat type 2 diabetes but has been discussed lately as regards overweight reduction medicines